Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1304-1307

  Hastings, J C ^a   Selnick, H ^a   Wolanski, B ^a   Tomassin, J E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [1 BENZYL 3 (4 CHLOROBENZYL) 3 PIPERIDINYL] 2,4 DIOXOBUTYRIC ACID; ANTIVIRUS AGENT; N ACETYL 2,3 DEHYDRO 2,4 DIDEOXY 4 GUANIDINONEURAMINIC ACID; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; DRUG CONFORMATION; DRUG EFFECT; DRUG POTENCY; DRUG SPECIFICITY; DRUG SYNTHESIS; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

EID: 0030007129     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1304     Document Type: Article

References (25)

1. Barrett, T., and S. C. Inglis. 1985. Growth, purification and titration of influenza viruses, p. 119-150. In B. W. S Mahy (ed.), Virology: a practical approach IRL Press, Oxford.
2. Braam, J., I. Ulmanen, and R. Krug. 1983. Molecular model of a eukaryotic transcription complex: functions and movements of influenza P protein during capped RNA-primed transcription Cell 34:609-618.
3. De la Luna, S., C. Martinez, and J. Ortin. 1989 Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res 13:143-155
4. Jin, H., and R. M. Elliott. 1993. Characterization of Bunyamwera virus S RNA that is transcribed and replicated by the L protein expressed from recombinant vaccinia virus. J. Virol. 67:1396-1404
5. Krug, R. M., F. V. Alonso-Caplan, I. Julkunen, and M. G. Katze. 1989. Expression and replication of the influenza virus genome, p. 89-152 In R. M. Kiug (ed.). The influenza viruses Plenum Press, New York.
6. Loosli, C. G. 1949. The pathogenesis and pathology of experimental airborne influenza virus A infection in mice. J. Infect. Dis. 84:153-168.
7. Nakagawa, Y., N. Kimura, T. Toyoda, K. Mizumoto, A. Ishihama, K. Oda, and S. Nakada. 1995. The RNA polymerase PB2 subunit is not required for replication of the influenza virus genome but is involved in capped mRNA synthesis. J. Virol. 69:728-733.
8. Nichol, S. T., C. R. Penn, and B. W. J. Mahy. 1981 Evidence for the involvement of influenza A (Fowl Plague Rostock) virus protein P2 in ApG and mRNA-primed in vitro RNA synthesis. J. Gen. Virol. 57:407-413
9. Novak, M., Z. Moldoveanu, D. P. Schafer, J. Mestecky, and R. W. Compans. 1993. Murine model for evaluation of protective immunity to influenza virus Vaccine 11:55-60.
10. Palese, P., M. B. Ritchey, and J. L. Schulman. 1977. P1 and P3 proteins of influenza virus are required for complementary RNA synthesis J. Virol. 21: 1187-1195.
11. Patterson, J. L., B. Holloway, and D. Kolakofsky. 1984. La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease. J. Virol 52:215-222.
12. 7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23: 847-858.
13. Renegar, K. B. 1992. Influenza virus infections and immunity: a review of human and animal models. Lab. Anim. Sci. 42:222-232.
14. Rossier, C. J., J. L. Patterson, and D. Kolakofsky. 1986. La Crosse virus small genome mRNA is made in the cytoplasm J. Virol. 58:647-650.
15. Ryan, D. M., J. Ticehurst, M. H. Dempsey, and C. R. Penn. 1994 Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38:2270-2275.
16. Rychlik, W., L. L. Domier, P. R. Gardner, G. M. Hellmann, and R. E. Rhoads. 1987. Amino acid sequence of the mRNA cap-binding protein from human tissue. Proc. Natl. Acad. Sci. USA 84:945-949.
17. Scheigetz, J., R. Zamboni, M. A. Bernstein, and B. Roy. 1995. A synthesis of 4-A-guanidino-2-deoxy-2,3-didehydro-W-acetylneuraminic acid. Org. Prep. Proc. Inter. 27:637-644.
18. 2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme. Virology 208:38-47.
19. 7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrob. Agents Chemother. 38:2827-2837.
20. 7GpppNm) on RNAs and in initiating viral RNA Transcription. Proc. Natl. Acad Sci. USA 78: 7355-7359.
21. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by infection of DNA encoding a viral protein. Science 259:1745-1749.
22. von Itzstein, M., W.-Y. Wu, G. B. Kok, M. S. Pegg, J. C. Dyason, B. Jin, T. V. Phan, M. L. Smythe, H. F. White, S. W. Oliver, P. M. Colman, J. N. Varghese, D. M. Ryan, J. M. Woods, R. C. Bethell, V. J. Hotham, J. M. Cameron, and C. R. Penn. 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature (London) 363:418-419.
23. Woods, J. M., R. C. Bethell, J. A. V. Coates, N. Healy, S. A. Hiscox, B. A. Pearson, D. M. Ryan, J. Ticehurst, J. Tilling, S. M. Walcott, and C. R. Penn. 1993 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acctylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother 37:1473-1479.
24. Yamashita, M., M. Krystal, and P. Palese. 1989. Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Virology 171: 458-466.
25. Yetter, R. A., S. Lehrer, R. Ramphal, and P. A. Small, Jr. 1980. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 29:654-662.